Aclaris Therapeutics (ACRS) Interest & Investment Income (2014 - 2026)

Aclaris Therapeutics' Interest & Investment Income history runs 6 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• In Q1 2026, Interest & Investment Income fell 30.1% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $7.0 million (down 14.06% YoY), while the FY2025 annual figure was $7.6 million, down 3.97% from the prior year.
• Interest & Investment Income was $1.5 million for Q1 2026 at Aclaris Therapeutics, down from $1.6 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $2.3 million in Q3 2023 to a low of $1.5 million in Q1 2026.
• Historically, Interest & Investment Income has averaged $2.0 million across 4 years, with a median of $2.0 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Interest & Investment Income grew 8.84% in 2025, then plunged 30.1% in 2026.
• A 4-year view of Interest & Investment Income shows it stood at $2.2 million in 2023, then fell by 3.93% to $2.1 million in 2024, then slipped by 22.3% to $1.6 million in 2025, then fell by 7.34% to $1.5 million in 2026.
• The last three Interest & Investment Income figures came in at $1.5 million (Q1 2026), $1.6 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.